Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Methods from The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti–PD-L1–Resistant Cancer
  1. Home
  2. Publications
  3. Supplementary Methods from The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti–PD-L1–Resistant Cancer

Supplementary Methods from The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti–PD-L1–Resistant Cancer

Authors:
  • JRJuliette Roels
    Juliette Roels
  • HGHamid Ghaedi
    Hamid Ghaedi
  • JKJayaram Kancherla
    Jayaram Kancherla
  • YYYiming Yang
    Yiming Yang
  • RGRamya Ganesan
    Ramya Ganesan
  • PBPriyanka Babu
    Priyanka Babu
  • KWKatherine Williams
    Katherine Williams
  • XYXiaosai Yao
    Xiaosai Yao
  • RPRachana Pradhan
    Rachana Pradhan
  • XGXiangnan Guan
    Xiangnan Guan
  • KYKobe Yuen
    Kobe Yuen
  • DMDanilo Maddalo
    Danilo Maddalo

Open Access
Publisher website
Google Scholar
  • 1 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.32530482
Abstract
Supplementary Methods for Firmament
Keywords
  • GENITOURINARY CANCERS
  • BLADDER CANCER
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • TUMOR MICROENVIRONMENT
  • TUMOR-STROMAL CELL INTERACTIONS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.